Medical
Biotechnology
Biopharmaceutical

Amgen

3,116

$230.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$5.57 (+2.49%) Today
+$0.31 (+0.13%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Amgen and other stocks, options, ETFs, and crypto commission-free!

About AMGN

Amgen Inc. Common Stock, also called Amgen, is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Read More Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

CEO
Robert A. Bradway
Employees
23,400
Headquarters
Thousand Oaks, California
Founded
1980
Market Cap
135.12B
Price-Earnings Ratio
18.00
Dividend Yield
2.79
Average Volume
3.28M
High Today
$230.57
Low Today
$222.13
Open Price
$224.63
Volume
4.25M
52 Week High
$244.99
52 Week Low
$166.68

Collections

Medical
Biotechnology
Biopharmaceutical
Health
Cancer Prevention
Pharmaceutical
Therapy
Manufacturing

AMGN News

ReutersMay 29

BRIEF-Amgen Presents New Amg 510 Clinical Data Across Multiple Solid Tumors

May 29 (Reuters) - Amgen Inc: * AMGEN PRESENTS NEW AMG 510 CLINICAL DATA ACROSS MULTIPLE SOLID TUMORS DURING ASCO20 VIRTUAL SCIENTIFIC PROGRAM * AMGEN INC - D
7
ReutersMay 25

Edited Transcript of CYTK earnings conference call or presentation 6-May-20 8:30pm GMT

Q1 2020 Cytokinetics Inc Earnings Call South San Francisco May 26, 2020 (Thomson StreetEvents) -- Edited Transcript of Cytokinetics Inc earnings conference cal
8

AMGN Earnings

$0.00
$1.39
$2.78
$4.17
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Jul 28, After Hours

You May Also Like

USFD
STAR
DLR-C
CURO
RCL
MOGO
UVSP
RNST
NSPR+
SPIB
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy AMGN

Market Price$230.01
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Amgen stock and options commission-free.
LearnBlogCareersHelpLog InSign Up